AIM
AVNS

Alambic Investment Management’s Avanos Medical AVNS Stock Holding History

Alambic Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,050
Closed -$1.16M – 464
2017
Q4 		$1.16M Sell
25,050
-5,700
-19% -$262K 0.14% 235
2017
Q3 		$1.39M Sell
30,750
-1,950
-6% -$83.2K 0.15% 216
2017
Q2 		$1.28M Sell
32,700
-4,100
-11% -$155K 0.16% 221
2017
Q1 		$1.4M Buy
36,800
+13,400
+57% +$522K 0.17% 194
2016
Q4 		$865K Buy
23,400
+2,400
+11% +$85.8K 0.15% 221
2016
Q3 		$728K Sell
21,000
-400
-2% -$14K 0.17% 208
2016
Q2 		$696K Buy
21,400
+10,700
+100% +$328K 0.17% 214
2016
Q1 		$307K Buy
+10,700
New +$285K 0.1% 316

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alambic Investment Management's AVNS Position: Q1 2018 in Review

Alambic Investment Management sold out of Avanos Medical (AVNS) in Q1 2018, closing a stake of 25,050 shares — an estimated $1.16M sold.

Alambic Investment Management first reported a position in AVNS in Q1 2016 and held it in 8 quarters. The position peaked at $1.4M in Q1 2017. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2018.

  • Alambic Investment Management reported no remaining Avanos Medical position as of Q1 2018 after selling out during the quarter.
  • Alambic Investment Management sold 25,050 Avanos Medical shares in Q1 2018, an estimated $1.16M.
  • Alambic Investment Management first reported a position in Avanos Medical in Q1 2016 and held it in 8 quarters.
  • Alambic Investment Management's Avanos Medical position peaked at $1.4M in Q1 2017.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2018.

Based on Alambic Investment Management's 13F filing for Q1 2018, filed 8 May 2018.